Three pediatric medical practices can proceed with a proposed class action accusing pharmaceutical company Merck of illegally stifling competition to its rotavirus vaccine RotaTeq after a judge rejected the drugmaker’s bid to send the case to arbitration.
US District Judge J. Curtis Joyner in Philadelphia ruled on Wednesday, January 23, that arbitration clauses contained in contracts Merck entered into with so-called physician buying groups through which the pediatricians bought the vaccines did not apply to their practices.
The suit is a class action by pediatricians alleging the pharma company used its monopoly in certain essential vaccines to unlawfully drive up prices on the rotavirus vaccine, which most children aren’t required to get.
The suit is the latest in a string of complaints about drugmakers that sell their medications through bundled discounts and penalize buyers who don’t take the entire bundle.
Full Content: Bloomberg & Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI